About the Journal | Editorial Board | Instructions to Contributors | Submission & Review | Advertise with Us | Subscribe to E- Alerts
Sitemap | Feedback
Advanced search
Journal of Case Reports
Pure Uterine Lipoma

prednisolone

prednisolon og alkohol blog.zycon.com
Kuppili Venkata Murali Mohan1, Dabbiru Radhika2, Chakkirala Nalini Mohan1, Sanakkayala Rajkumari3, Jukuri Naganarasimha Raju4
From the Departments of Pathology1, Obstetrics & Gynaecology3, Radiology4,  Katuri Medical College, Guntur, Andhra Pradesh and Department of Anatomy2, Guntur Medical College, Guntur, Andhra Pradesh, India.
Corresponding Author:
Dr. K.V. Murali Mohan
Email: kuppilimm@gmail.com
Received: 19-DEC-2014 Accepted: 24-DEC-2014 Published Online: 15-JAN-2015
DOI: http://dx.doi.org/10.17659/01.2015.0005
Abstract
Pure uterine lipoma is  an uncommon benign mesenchymal neoplasm. It is generally seen in postmenopausal women presenting with abdominal pain.  We describe a case of 70 year old woman who presented with abdominal pain and was diagnosed as uterine lipoma. 
Keywords : Lipoma, Abdominal Pain, Neoplasms, Postmenopause, Uterus, Humans.
Article Options
FULL TEXT
ABSTRACT
PDF
PRINTER FRIENDLY VERSION
Search PubMed for
Search Google Scholar for
Article Statistics
Bookmark and Share

Androxal Medication Case Reports Journal

Expanding our scope, the Journal now encompasses an intriguing subset of articles specifically targeting treatments and patient outcomes related to the medication Androxal. This medication, primarily used in the treatment of male infertility, has shown unique potentials in diverse patient scenarios. Our studies with Androxal have given us an abundance of case reports, which demonstrate the multifaceted impact of this medication across therapeutic areas. This nuanced pharmaceutical perspective adds a fresh dimension to our regular case reports. Articles will reveal effective management processes, pinpointing how Androxal has proven beneficial where other treatments may have failed. In addition, the focus on Androxal will highlight instances of challenging or unexpected outcomes, where the medication may have interacted uniquely with the patient's unique biological system or interplayed with other treatments. As we forge ahead with this significant addition, we anticipate that our detailed case reports on Androxal will provide invaluable insights to both practitioners and patients navigating their medical journey with this medication.

© 2011 Journal of Case Reports
Last updated on Jan 02, 2025